Anzeige
Mehr »
Login
Samstag, 19.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Trumps Dekret beschleunigt Antimon-Boom - Wird Global Tactical der nächste Highflyer für kritische Mineralien?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

JCN Newswire-Archiv vom 15.04.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DiHKTDC: Standard Chartered GBA Business Confidence Survey shows calm before tariff storm in Q1160HONG KONG, Apr 15, 2025 - (ACN Newswire) - The latest Standard Chartered GBA Business Confidence Index (GBAI) jointly published by Standard Chartered and the Hong Kong Trade Development Council (HKTDC)...
► Artikel lesen
DiFujitsu Ltd: Isuzu and Fujitsu sign partnership agreement to commercialize software defined vehicles231Yokohama and Kawasaki, Japan, Apr 15, 2025 - (JCN Newswire) - Isuzu Motors Limited and Fujitsu Limited today announced the signing of a partnership agreement to strengthen the development of competitive...
► Artikel lesen
DiMitsubishi Heavy Industries, Ltd.: MHI Awarded a Study on CO2 Capture Modules for FPSOs314- Study for the application of CO2 Capture Modules on FPSOs under planning by Petrobras- Partnership with SBM Offshore, a deepwater ocean infrastructure expert, to apply innovative CO2capture technologies...
► Artikel lesen
DiCTF Life Supports 10 Local Schools with Donations of Dr MAC Classroom Reading Programme and Learning Living Chinese Programme254- Promotes Chinese culture and Dr. Cheng Yu-Tung's legacy of advocating positive valuesHONG KONG, Apr 15, 2025 - (ACN Newswire) - CTF Life participated in the donation ceremony for the Dr MAC Classroom...
► Artikel lesen
DiHighTide Therapeutics Inc.: Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA312- HighTide Therapeutics Announces HTD1801 Meets the Primary Endpoints in Two Phase 3 Clinical Trials in Patients with Type 2 Diabetes MellitusHONG KONG, Apr 15, 2025 - (ACN Newswire) - HighTide Therapeutics...
► Artikel lesen